Skip to main content

Arcadia Biosciences, Inc.

corporate_fare Company Profile

Arcadia Biosciences, Inc.

RKDA·NASDAQ·Life Sciences·CIK 0001469443

Arcadia develops high-value products and drives innovation in the consumer goods industry. Since acquiring the assets of Zola in May 2021, Arcadia has provided consumers with Zola coconut water products for rehydration, resetting, and reenergizing. Previously, Arcadia developed products, primarily in wheat, which it commercialized through the sale of food products, trait licensing, and royalty agreements. On May 14, 2024, Arcadia sold its non-GMO Resistant Starch ("RS") durum wheat trait to Corteva Agriscience for total cash consideration of $4.0 million. On May 16, 2024, Arcadia sold the GoodWheat™ brand to Above Food for net consideration of $3.7 million. The assets sold consisted primarily of grain and finished goods inventories, formulations, and trademarks. On December 4, 2024, Arcadia, Roosevelt Resources LP, and Elliott Roosevelt, Jr. and David A. Roosevelt, as representatives of the limited partners of Roosevelt, entered into a Securities Exchange Agreement for the combination of the two companies in an all-stock transaction. Arcadia agreed to issue shares of its common stock to the limited partners and the sole member of the general partner of Roosevelt in exchange for all of the limited partnership and other equity interests of Roosevelt.

Arcadia Biosciences, Inc. (NASDAQ:RKDA) is a publicly traded company in the Life Sciences sector. Wiseek monitors RKDA SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Distressed Arcadia Biosciences Closes $4M Private Placement, Bolstering Liquidity
  • $4M Private Placement Provides Lifeline for Financially Distressed Arcadia Biosciences
  • Arcadia Biosciences Reports Q1 Loss, Reiterates Going Concern, and Discloses Major Debt Default
  • Arcadia Biosciences Swings to $4.4M Net Loss in Q1, Operating Expenses Soar 180%
  • Arcadia Biosciences Dismisses Deloitte, Appoints New Auditor Amidst Financial Distress

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$4.86M
Net Income
-$2.34M
Diluted EPS
-$1.71
Op. Cash Flow
-$4.74M
Free Cash Flow
-$4.74M
Gross Profit
$1.76M
Operating Income
-$2.5M
Cash & Equivalents
$259K
Debt / Equity
0.00×
Net Margin
-48.1%
Shares Outstanding
1.37M sh
Source: 10-K · filed 2026-04-30 · accession 0001193125-26-197315
Browse all tickers starting with R →
$0.98 -0.05% today
52-week range · as of 2026-05-14 $0.89 – $6.71
Market cap
$2.12M
Volume
2.6M (0.4× avg)
3-mo avg 6.3M
Live data · 2026-06-14 05:16 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed RKDA - Latest Insights

RKDA
Jun 12, 2026, 10:00 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.980
Real-time Price: $0.980 info
Change: $0 (0%) info
Market Cap: $2.119M info
RKDA
Jun 11, 2026, 8:00 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.17
Real-time Price: $0.980 info
Change: -$0.190 (-16%) info
Market Cap: $2.119M info
RKDA
May 14, 2026, 4:07 PM EDT
Filing Type: 10-Q
Importance Score:
10
Price at Filing: $1.05
Real-time Price: $0.980 info
Change: -$0.073 (-7%) info
Market Cap: $2.119M info
RKDA
May 14, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.07
Real-time Price: $0.980 info
Change: -$0.090 (-8%) info
Market Cap: $2.119M info
RKDA
Apr 03, 2026, 3:31 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.38
Real-time Price: $0.980 info
Change: -$0.3978 (-29%) info
Market Cap: $2.119M info
RKDA
Mar 26, 2026, 4:09 PM EDT
Filing Type: 10-K
Importance Score:
10
Price at Filing: $1.52
Real-time Price: $0.980 info
Change: -$0.5378 (-35%) info
Market Cap: $2.119M info
RKDA
Mar 26, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.52
Real-time Price: $0.980 info
Change: -$0.5378 (-35%) info
Market Cap: $2.119M info
RKDA
Mar 26, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.69
Real-time Price: $0.980 info
Change: -$0.710 (-42%) info
Market Cap: $2.119M info
RKDA
Feb 10, 2026, 6:41 PM EST
Filing Type: 424B3
Importance Score:
9
Price at Filing: $1.80
Real-time Price: $0.980 info
Change: -$0.8234 (-46%) info
Market Cap: $2.119M info
RKDA
Feb 06, 2026, 4:03 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.80
Real-time Price: $0.980 info
Change: -$0.820 (-46%) info
Market Cap: $2.119M info
RKDA
Jan 27, 2026, 8:45 PM EST
Filing Type: S-3
Importance Score:
9
Price at Filing: $2.23
Real-time Price: $0.980 info
Change: -$1.25 (-56%) info
Market Cap: $2.119M info
RKDA
Jan 13, 2026, 8:07 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.55
Real-time Price: $0.980 info
Change: -$1.57 (-62%) info
Market Cap: $2.119M info